Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL429848 | 0.94 | — | — | |
| Alcohol SCHEMBL28289082 | 0.94 | — | — | |
| Alcohol SCHEMBL11221815 | 0.88 | — | — | |
| Alcohol SCHEMBL7697616 | 0.88 | — | — | |
| Alcohol SCHEMBL28412704 | 0.88 | — | — | |
| Alcohol SCHEMBL29250791 | 0.88 | — | — | |
| Alcohol SCHEMBL9407034 | 0.88 | — | — | |
| Alcohol SCHEMBL563566 | 0.88 | — | — | |
| Alcohol SCHEMBL28984408 | 0.88 | — | — | |
| Alcohol SCHEMBL28012548 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117720591-A | Synthesis method of 14-methyl ether epirubicin | 浙江亚瑟医药有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-111499579-A | Preparation method of dabigatran etexilate impurity | 廊坊市泽康医药科技有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-117720591-A | Synthesis method of 14-methyl ether epirubicin | 浙江亚瑟医药有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-114685399-A | Preparation method of urapidil intermediate 1- (2-methoxyphenyl) piperazine and salt thereof | 河北广祥制药有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-111499579-A | Preparation method of dabigatran etexilate impurity | 廊坊市泽康医药科技有限公司 | 2020-08-07 | — | — | CN | disclosed |
| CN-111499579-A | Preparation method of dabigatran etexilate impurity | 廊坊市泽康医药科技有限公司 | 2020-08-07 | — | — | CN | disclosed |
| CN-108774278-A | A method of preparing niacinamide nucleosides salt | 张洪喜 | 2018-11-09 | — | — | CN | disclosed |
| CN-106496208-A | The preparation method of emtricitabine | 上海博志研新药物技术有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-106478618-A | The preparation method of emtricitabine halogen acid salt | 上海礼泰医药科技有限公司 | 2017-03-08 | — | — | CN | disclosed |
| EP-2123644-B1 | BENZOXAZEPINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2014-12-17 | — | — | EP | disclosed |
| US-8247403-B2 | Benzoxazepine derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| US-20100087418-A1 | BENZOXAZEPINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2010-04-08 | — | — | US | disclosed |
| EP-2123644-A1 | BENZOXAZEPINE DERIVATIVES AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-20060252800-A1 | Anti-leishmania agent | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2006-11-09 | — | — | US | disclosed |
| EP-1623981-A1 | ANTI-LEISHMANIA AGENT | Japan Science and Technology Corporation (JP) | 2006-02-08 | — | — | EP | disclosed |
| EP-0456799-A1 | IMPROVED METHOD OF PREPARING AN INTERMEDIATE FOR THE MANUFACTURE OF BAMBUTEROL. | ASTRA AB (SE) | 1991-11-21 | — | — | EP | disclosed |
| WO-1991008197-A1 | IMPROVED METHOD OF PREPARING AN INTERMEDIATE FOR THE MANUFACTURE OF BAMBUTEROL | AKTIEBOLAGET ASTRA (SE) | 1991-06-13 | — | — | WO | disclosed |
| US-4323575-A | TOPICAL ANTIINFLAMMATORY AGENTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-04-06 | — | — | US | disclosed |